Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Hantaan virus glycoproteins Gn and Gc are the primary surface components of the Hantaan orthohantavirus (HTNV), the prototype virus causing Hemorrhagic Fever with Renal Syndrome (HFRS) (UniProt: P08668). These glycoproteins are synthesized as a single precursor polyprotein from the viral M segment and are subsequently cleaved into Gn and Gc, which assemble into heterodimeric spikes on the viral envelope. Gn is primarily responsible for host cell attachment by interacting with receptors such as beta-3 integrins and decay-accelerating factor (DAF), while Gc acts as a class II fusion protein that facilitates the merger of viral and host membranes in the acidic environment of the endosome (PubMed: 30653203). As the only proteins exposed on the virion surface, they are the critical targets for the host's neutralizing antibody response and the primary focus for vaccine development. Current therapeutic strategies include the use of inactivated vaccines like Hantavax and the development of DNA vaccines and neutralizing monoclonal antibodies designed to block viral entry (PubMed: 29445145). Understanding the structural and functional roles of Gn and Gc is essential for developing broad-spectrum countermeasures against various hantaviruses.
Neutralization of viral entry by blocking receptor binding or preventing pH-dependent membrane fusion.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hantaan virus glycoproteins Gn and Gc (Gn/Gc).